Edison’s Kosmos AI scientist moves into Pfizer R&D; Edison details the math behind its $99 million-per-program estimate
Edison Scientific explains how Kosmos cites its sources and where its 75% IND-time and $99 million figures come from as it deploys across Pfizer R&D.